AnaptysBio’s drug candidates rosnilimab and ANB032 hold key trial results ahead. Find out why ANAB stock is impacted by immunology competition and risks.

Two Sigma Investments will dismiss roughly 200 employees after the firm’s new co-chief executive officers conducted a ...

Dazz will be the force multiplier for Wiz Code, Wiz’s latest product, designed to secure the application lifecycle with a ...

csUSDL is seamlessly integrated with the broader DeFi ecosystem. Users have opportunities to access token incentives from ...

A Costly AffairLiverpool’s management is currently facing a critical phase as they consider the future of their defensive ...

Organize the chaos with these free digital social media planners for Excel, Google Sheets, monday.com, ClickUp, Wrike, and ...

Bisnow's annual San Francisco Multifamily and Affordable Housing Conference will cover rate cuts, evolving resident demands, ...

Snowflake impresses with strong product revenue growth, but profitability issues remain.

The changes in society and the phenomena surrounding us are becoming more unexpected and interconnected than ever before.

Leading Nordic operator unveils ‘game-changer’ analytics and insights service for businesses looking to make use of the full ...

As the risk environment for higher education continues to expand, an enterprise-wide approach that links ERM with strategic ...

The Federal Emergency Management Agency is facing scrutiny for its spending on diversity, equity and inclusion policies.